Skip to main content

Predictors of disease progression in pediatric dilated cardiomyopathy.

Publication ,  Journal Article
Molina, KM; Shrader, P; Colan, SD; Mital, S; Margossian, R; Sleeper, LA; Shirali, G; Barker, P; Canter, CE; Altmann, K; Radojewski, E ...
Published in: Circ Heart Fail
November 2013

BACKGROUND: Despite medical advances, children with dilated cardiomyopathy (DCM) remain at high risk of death or need for cardiac transplantation. We sought to identify predictors of disease progression in pediatric DCM. METHODS AND RESULTS: The Pediatric Heart Network evaluated chronic DCM patients with prospective echocardiographic and clinical data collection during an 18-month follow-up. Inclusion criteria were age <22 years and DCM disease duration >2 months. Patients requiring intravenous inotropic/mechanical support or listed status 1A/1B for transplant were excluded. Disease progression was defined as an increase in transplant listing status, hospitalization for heart failure, intravenous inotropes, mechanical support, or death. Predictors of disease progression were identified using Cox proportional hazards modeling and classification and regression tree analysis. Of the 127 patients, 28 (22%) had disease progression during the 18-month follow-up. Multivariable analysis identified older age at diagnosis (hazard ratio=1.14 per year; P<0.001), larger left ventricular (LV) end-diastolic M-mode dimension z-score (hazard ratio=1.49; P<0.001), and lower septal peak systolic tissue Doppler velocity z-score (hazard ratio=0.81; P=0.01) as independent predictors of disease progression. Classification and regression tree analysis stratified patients at risk of disease progression with 89% sensitivity and 94% specificity based on LV end-diastolic M-mode dimension z-score ≥7.7, LV ejection fraction <39%, LV inflow propagation velocity (color M-mode) z-score <-0.28, and age at diagnosis ≥8.5 months. CONCLUSIONS: In children with chronic stable DCM, a combination of diagnosis after late infancy and echocardiographic parameters of larger LV size and systolic and diastolic function predicted disease progression. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00123071.

Duke Scholars

Published In

Circ Heart Fail

DOI

EISSN

1941-3297

Publication Date

November 2013

Volume

6

Issue

6

Start / End Page

1214 / 1222

Location

United States

Related Subject Headings

  • Ventricular Function, Left
  • Time Factors
  • Prospective Studies
  • Prognosis
  • Male
  • Infant
  • Humans
  • Heart Ventricles
  • Heart Transplantation
  • Follow-Up Studies
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Molina, K. M., Shrader, P., Colan, S. D., Mital, S., Margossian, R., Sleeper, L. A., … Pediatric Heart Network Investigators, . (2013). Predictors of disease progression in pediatric dilated cardiomyopathy. Circ Heart Fail, 6(6), 1214–1222. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000125
Molina, Kimberly M., Peter Shrader, Steven D. Colan, Seema Mital, Renee Margossian, Lynn A. Sleeper, Girish Shirali, et al. “Predictors of disease progression in pediatric dilated cardiomyopathy.Circ Heart Fail 6, no. 6 (November 2013): 1214–22. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000125.
Molina KM, Shrader P, Colan SD, Mital S, Margossian R, Sleeper LA, et al. Predictors of disease progression in pediatric dilated cardiomyopathy. Circ Heart Fail. 2013 Nov;6(6):1214–22.
Molina, Kimberly M., et al. “Predictors of disease progression in pediatric dilated cardiomyopathy.Circ Heart Fail, vol. 6, no. 6, Nov. 2013, pp. 1214–22. Pubmed, doi:10.1161/CIRCHEARTFAILURE.113.000125.
Molina KM, Shrader P, Colan SD, Mital S, Margossian R, Sleeper LA, Shirali G, Barker P, Canter CE, Altmann K, Radojewski E, Tierney ESS, Rychik J, Tani LY, Pediatric Heart Network Investigators. Predictors of disease progression in pediatric dilated cardiomyopathy. Circ Heart Fail. 2013 Nov;6(6):1214–1222.

Published In

Circ Heart Fail

DOI

EISSN

1941-3297

Publication Date

November 2013

Volume

6

Issue

6

Start / End Page

1214 / 1222

Location

United States

Related Subject Headings

  • Ventricular Function, Left
  • Time Factors
  • Prospective Studies
  • Prognosis
  • Male
  • Infant
  • Humans
  • Heart Ventricles
  • Heart Transplantation
  • Follow-Up Studies